(Q35695410)

English

ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.

scientific article published on 14 April 2015

Statements

ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit